LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 216

Search options

  1. Article ; Online: Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease.

    Martin, Paul J / Storer, Barry E / Levine, David M / Hansen, John A

    Blood advances

    2021  Volume 5, Issue 21, Page(s) 4456–4464

    Abstract: Previous studies have identified genetic variants associated with inflammatory bowel disease (IBD). We tested the hypothesis that some of these variants are also associated with the risk of moderate to severe gut graft-versus-host disease (GVHD) after ... ...

    Abstract Previous studies have identified genetic variants associated with inflammatory bowel disease (IBD). We tested the hypothesis that some of these variants are also associated with the risk of moderate to severe gut graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). Associations were evaluated initially in a discovery cohort of 1980 HCT recipients of European ancestry with HLA-matched related or unrelated donors. Associations discovered in this cohort were tested for replication in a separate cohort of 1294 HCT recipients. Among the 296 single-nucleotide polymorphisms and 26 HLA alleles tested, we found that the recipient rs1260326 homozygous T allele in GCKR was associated with a higher risk of stage 2 to 4 gut GVHD. No other candidate variants were associated with stage 2 to 4 gut GVHD. The rs1260326 variant resides in an IBD-associated locus containing FNDC4, a gene that encodes a secreted anti-inflammatory factor that dampens macrophage activity and improves colitis in mice. Our results suggest that targeting inflammatory macrophages with recombinant FNDC4 offers an attractive avenue of clinical investigation for management of IBD and gut GVHD.
    MeSH term(s) Animals ; Colitis ; Graft vs Host Disease/genetics ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Inflammatory Bowel Diseases/genetics ; Mice ; Proteins ; Unrelated Donors
    Chemical Substances FNDC4 protein, human ; Proteins
    Language English
    Publishing date 2021-09-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2021004959
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Response.

    Bhatia, Shailender / Storer, Barry E / Nghiem, Paul

    Journal of the National Cancer Institute

    2017  Volume 109, Issue 10

    Language English
    Publishing date 2017-07-03
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2992-0
    ISSN 1460-2105 ; 0027-8874 ; 0198-0157
    ISSN (online) 1460-2105
    ISSN 0027-8874 ; 0198-0157
    DOI 10.1093/jnci/djx053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia-Reply.

    Sorror, Mohamed L / Storer, Barry E / Estey, Elihu H

    JAMA oncology

    2018  Volume 4, Issue 7, Page(s) 1014–1015

    MeSH term(s) Cognition ; Humans ; Leukemia, Myeloid, Acute ; Risk Assessment
    Language English
    Publishing date 2018-07-18
    Publishing country United States
    Document type Letter ; Comment
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2018.0677
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification.

    Sorror, Mohamed L / Storer, Barry E / Nyland, Jennifer / Estey, Elihu H

    JAMA oncology

    2019  Volume 5, Issue 7, Page(s) 1062–1064

    MeSH term(s) Humans ; Leukemia, Myeloid, Acute/classification ; Models, Biological ; Platelet Count ; Risk
    Language English
    Publishing date 2019-05-16
    Publishing country United States
    Document type Journal Article
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2019.0902
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation.

    Martin, Paul J / Levine, David M / Storer, Barry E / Sather, Cassandra L / Spellman, Stephen R / Hansen, John A

    Blood advances

    2022  Volume 6, Issue 8, Page(s) 2608–2617

    Abstract: Previous studies have identified more than 200 genetic variants associated with acute or chronic graft-versus-host disease (aGVHD; cGVHD) or recurrent malignancy after allogeneic hematopoietic cell transplantation (HCT). We tested these candidate donor ... ...

    Abstract Previous studies have identified more than 200 genetic variants associated with acute or chronic graft-versus-host disease (aGVHD; cGVHD) or recurrent malignancy after allogeneic hematopoietic cell transplantation (HCT). We tested these candidate donor and recipient variants in a cohort of 4270 HCT recipients of European ancestry and in subcohorts of 1827 sibling and 1447 unrelated recipients who had 10/10 HLA-A, B, C, DRB1, and DQB1-matched donors. We also carried out a genome-wide association study (GWAS) for these same outcomes. The discovery and replication analysis of candidate variants identified a group of closely linked recipient HLA-DPB1 single-nucleotide polymorphisms (SNPs) associated with an increased risk of aGVHD and a corresponding decreased risk of recurrent malignancy after unrelated HCT. These results reflect a correlation with the level of HLA-DPB1 expression previously shown to affect the risks of aGVHD and relapse in unrelated recipients. Our GWAS identified an association of cGVHD with a locus of X-linked recipient intron variants in NHS, a gene that regulates actin remodeling and cell morphology. Evaluation of this association in a second replication cohort did not confirm the original replication results, and we did not reach any definitive conclusion regarding the validity of this discovery. The cohort used for our study is larger than those used in most previous HCT studies but is smaller than those typically used for other genotype-phenotype association studies. Genomic and disease data from our study are available for further analysis in combination with data from other cohorts.
    MeSH term(s) Chronic Disease ; Genome-Wide Association Study ; Graft vs Host Disease/genetics ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Recurrence ; Siblings ; Tissue Donors
    Language English
    Publishing date 2022-01-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2021005620
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Statistical considerations in studies of late effects in HCT.

    Storer, Barry E

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

    2009  Volume 15, Issue 1 Suppl, Page(s) 25–28

    MeSH term(s) Graft vs Host Disease ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/mortality ; Hematopoietic Stem Cell Transplantation/statistics & numerical data ; Humans ; Survival Analysis ; Transplantation, Autologous
    Language English
    Publishing date 2009-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1474865-4
    ISSN 1523-6536 ; 1083-8791
    ISSN (online) 1523-6536
    ISSN 1083-8791
    DOI 10.1016/j.bbmt.2008.10.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

    Casto, Amanda M / Seo, Sachiko / Levine, David M / Storer, Barry E / Dong, Xinyuan / Hansen, John A / Boeckh, Michael / Martin, Paul J

    Blood

    2021  Volume 138, Issue 17, Page(s) 1628–1636

    Abstract: Human cytomegalovirus (CMV) reactivation is a frequent complication of allogeneic hematopoietic cell transplantation (HCT). Despite routine screening for CMV reactivation and early antiviral treatment, the rates of CMV-related complications after HCT ... ...

    Abstract Human cytomegalovirus (CMV) reactivation is a frequent complication of allogeneic hematopoietic cell transplantation (HCT). Despite routine screening for CMV reactivation and early antiviral treatment, the rates of CMV-related complications after HCT remain high. Genetic variants in both the donor and recipient have been associated with the risk of CMV reactivation and disease after HCT, but these associations have not been validated, and their clinical importance remains unclear. In this study, we assessed 117 candidate variants previously associated with CMV-related phenotypes for association with CMV reactivation and disease in a cohort of 2169 CMV-seropositive HCT recipients. We also carried out a genome-wide association study (GWAS) for CMV reactivation and disease in the same cohort. Both analyses used a prespecified discovery and replication approach to control the risk of false-positive results. Among the 117 candidate variants, our analysis implicates only the donor ABCB1 rs1045642 genotype as a risk factor for CMV reactivation. This synonymous variant in P-glycoprotein may influence the risk of CMV reactivation by altering the efflux of cyclosporine and tacrolimus from donor lymphocytes. In the GWAS analysis, the donor CDC42EP3 rs11686168 genotype approached the significance threshold for association with CMV reactivation, although we could not identify a mechanism to explain this association. The results of this study suggest that most genomic variants previously associated with CMV phenotypes do not significantly alter the risk for CMV reactivation or disease after HCT.
    MeSH term(s) ATP Binding Cassette Transporter, Subfamily B/genetics ; Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cytomegalovirus/isolation & purification ; Cytomegalovirus/physiology ; Cytomegalovirus Infections/etiology ; Cytomegalovirus Infections/genetics ; Female ; GTP-Binding Protein Regulators/genetics ; Genome-Wide Association Study ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Transplantation, Homologous/adverse effects ; Virus Activation ; Young Adult
    Chemical Substances ABCB1 protein, human ; ATP Binding Cassette Transporter, Subfamily B ; CDC42EP3 protein, human ; GTP-Binding Protein Regulators
    Language English
    Publishing date 2021-07-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2021012153
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting.

    Granot, Noa / Storer, Barry E / Cooper, Jason P / Flowers, Mary E / Sandmaier, Brenda M / Storb, Rainer

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

    2019  Volume 25, Issue 11, Page(s) 2152–2159

    Abstract: Conditioning with fludarabine and low-dose total-body irradiation before allogeneic hematopoietic cell transplantation (HCT) enabled treating older or medically infirm patients with advanced hematologic malignancies in the outpatient setting. Between ... ...

    Abstract Conditioning with fludarabine and low-dose total-body irradiation before allogeneic hematopoietic cell transplantation (HCT) enabled treating older or medically infirm patients with advanced hematologic malignancies in the outpatient setting. Between December 1997 and June 2017, 1037 patients with hematologic malignancies received peripheral blood stem cell (PBSC) grafts from HLA-matched or 1 HLA antigen/allele-mismatched related or unrelated donors. Median age was 58 (range, 18 to 80) years. Serious comorbidities with Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) scores ≥3 were present in 52% of patients. We found that 47% of patients were either never hospitalized or only had an overnight hospital stay for infusion of late-arriving PBSCs while 53% were admitted for a median of 6 days. Main reasons for admission were infection, fever, graft-versus-host disease, and regimen-related toxicity. Two thirds of admissions occurred within 3 weeks of HCT. The 5-year risk of nonrelapse mortality (NRM) was 26% among hospitalized patients and 13% among nonhospitalized patients. Significant risk factors for hospitalization included unrelated transplants, 1 HLA antigen-mismatched transplant, high HCT-CI scores, and diagnosis of nonmyeloma malignancies. Significant risk factors for NRM were hospitalization, older age, unrelated transplants, and high HCT-CI scores. Ambulatory allogeneic HCT is feasible and safe.
    MeSH term(s) Adolescent ; Adult ; Aged ; Allografts ; Ambulatory Care ; Disease-Free Survival ; Female ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; Humans ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation ; Prospective Studies ; Retrospective Studies ; Survival Rate
    Language English
    Publishing date 2019-06-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1474865-4
    ISSN 1523-6536 ; 1083-8791
    ISSN (online) 1523-6536
    ISSN 1083-8791
    DOI 10.1016/j.bbmt.2019.06.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Second allogeneic hematopoietic cell transplantation for relapse after first allografts.

    Gyurkocza, Boglarka / Storb, Rainer / Chauncey, Thomas R / Maloney, David G / Storer, Barry E / Sandmaier, Brenda M

    Leukemia & lymphoma

    2019  Volume 60, Issue 7, Page(s) 1758–1766

    Abstract: We analyzed outcomes of 126 patients with hematologic malignancies, who relapsed after first allogeneic hematopoietic cell transplantation (HCT) and received subsequent allografts. In 17 cases, the original donors were utilized, while in 109 cases ... ...

    Abstract We analyzed outcomes of 126 patients with hematologic malignancies, who relapsed after first allogeneic hematopoietic cell transplantation (HCT) and received subsequent allografts. In 17 cases, the original donors were utilized, while in 109 cases different donors were identified. The 2-year overall survival (OS), relapse, and non-relapse mortality (NRM) rates were 33%, 42%, and 33%, respectively. Patients with early relapse after first allogeneic HCT (within 100 days vs. 100 days to 12 months vs. >12 months) had higher relapse rates (50% vs. 47% vs. 34%, respectively;
    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/mortality ; Graft vs Host Disease/pathology ; Graft vs Host Disease/therapy ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/pathology ; Hematologic Neoplasms/therapy ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; New York/epidemiology ; Prognosis ; Retrospective Studies ; Survival Rate ; Transplantation Conditioning ; Transplantation, Homologous ; Unrelated Donors ; Young Adult
    Language English
    Publishing date 2019-01-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.1080/10428194.2018.1542149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20

    Granot, Noa / Rezvani, Andrew R / Pender, Barbara S / Storer, Barry E / Sandmaier, Brenda M / Storb, Rainer / Maloney, David G

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

    2020  Volume 26, Issue 10, Page(s) 1811–1818

    Abstract: We previously reported a 24% 1-year relapse rate in 93 older or medically unfit patients with ... ...

    Abstract We previously reported a 24% 1-year relapse rate in 93 older or medically unfit patients with CD20
    MeSH term(s) B-Lymphocytes ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation ; Humans ; Neoplasm Recurrence, Local ; Prospective Studies ; Receptors, Fc/genetics ; Rituximab/therapeutic use ; Transplantation Conditioning ; Transplantation, Homologous
    Chemical Substances Receptors, Fc ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2020-07-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1474865-4
    ISSN 1523-6536 ; 1083-8791
    ISSN (online) 1523-6536
    ISSN 1083-8791
    DOI 10.1016/j.bbmt.2020.07.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top